Today at WPR, we’re covering a significant vulnerability in the Russia-China strategic partnership and China’s global development ambitions.
But first, here’s our take on today’s top story:
Malaria vaccine: The World Health Organization has approved a new anti-malaria vaccine. The R21/Matrix-M, developed by Oxford University, is the second such vaccine to be recommended by the WHO and offers a cheaper and more accessible option to combat the disease. (Washington Post)